Subbu Nambi
Stock Analyst at Guggenheim
(4.98)
# 41
Out of 5,023 analysts
196
Total ratings
78.2%
Success rate
52.6%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Reiterated: Buy | $25 → $32 | $28.35 | +12.87% | 6 | Oct 1, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $125 → $128 | $105.90 | +20.87% | 7 | Oct 1, 2026 | |
| BRKR Bruker | Reiterated: Buy | $70 → $72 | $63.24 | +13.85% | 11 | Oct 1, 2026 | |
| CYRX Cryoport | Reiterated: Buy | $16 → $19 | $17.43 | +9.01% | 6 | Oct 1, 2026 | |
| DHR Danaher | Reiterated: Buy | $200 → $250 | $214.06 | +16.79% | 9 | Oct 1, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 → $200 | $177.80 | +12.49% | 18 | Oct 1, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 → $155 | $143.26 | +8.19% | 13 | Oct 1, 2026 | |
| ILMN Illumina | Reiterated: Buy | $226 → $305 | $273.04 | +11.71% | 14 | Oct 1, 2026 | |
| NTRA Natera | Reiterated: Buy | $360 → $475 | $410.35 | +15.75% | 9 | Oct 1, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $65 → $92 | $76.63 | +20.06% | 12 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $212 | $188.67 | +12.37% | 10 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 → $490 | $425.21 | +15.24% | 7 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $83 | $73.09 | +13.56% | 9 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $12.15 | +15.23% | 9 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $16.32 | +28.68% | 1 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $45.81 | +41.89% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.96 | +104.08% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.90 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $35.60 | +32.02% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $16.28 | -20.15% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $8.07 | -13.26% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $181.70 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.54 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.47 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $151.53 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €251.40 | +4.61% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $28.30 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.54 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $93.50 | n/a | 2 | Feb 23, 2025 |
Adaptive Biotechnologies
Oct 1, 2026
Reiterated: Buy
Price Target: $25 → $32
Current: $28.35
Upside: +12.87%
BillionToOne
Oct 1, 2026
Reiterated: Buy
Price Target: $125 → $128
Current: $105.90
Upside: +20.87%
Bruker
Oct 1, 2026
Reiterated: Buy
Price Target: $70 → $72
Current: $63.24
Upside: +13.85%
Cryoport
Oct 1, 2026
Reiterated: Buy
Price Target: $16 → $19
Current: $17.43
Upside: +9.01%
Danaher
Oct 1, 2026
Reiterated: Buy
Price Target: $200 → $250
Current: $214.06
Upside: +16.79%
Guardant Health
Oct 1, 2026
Reiterated: Buy
Price Target: $190 → $200
Current: $177.80
Upside: +12.49%
GRAIL
Oct 1, 2026
Reiterated: Buy
Price Target: $75 → $155
Current: $143.26
Upside: +8.19%
Illumina
Oct 1, 2026
Reiterated: Buy
Price Target: $226 → $305
Current: $273.04
Upside: +11.71%
Natera
Oct 1, 2026
Reiterated: Buy
Price Target: $360 → $475
Current: $410.35
Upside: +15.75%
Tempus AI
Oct 1, 2026
Reiterated: Buy
Price Target: $65 → $92
Current: $76.63
Upside: +20.06%
Oct 1, 2026
Reiterated: Buy
Price Target: $107 → $212
Current: $188.67
Upside: +12.37%
Oct 1, 2026
Reiterated: Buy
Price Target: $440 → $490
Current: $425.21
Upside: +15.24%
Oct 1, 2026
Reiterated: Buy
Price Target: $74 → $83
Current: $73.09
Upside: +13.56%
Sep 29, 2026
Reiterated: Buy
Price Target: $12 → $14
Current: $12.15
Upside: +15.23%
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $16.32
Upside: +28.68%
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $45.81
Upside: +41.89%
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $1.96
Upside: +104.08%
May 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.90
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $47
Current: $35.60
Upside: +32.02%
May 7, 2026
Reiterated: Buy
Price Target: $13
Current: $16.28
Upside: -20.15%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $8.07
Upside: -13.26%
Feb 24, 2026
Reiterated: Hold
Price Target: n/a
Current: $181.70
Upside: -
Feb 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.54
Upside: -
Oct 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.47
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $151.53
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €251.40
Upside: +4.61%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $28.30
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Feb 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $93.50
Upside: n/a